Stanley Laman Group Ltd. reduced its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 44.4% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 2,138 shares of the company's stock after selling 1,710 shares during the period. Stanley Laman Group Ltd.'s holdings in Procter & Gamble were worth $341,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of the stock. MOKAN Wealth Management Inc. raised its position in shares of Procter & Gamble by 13.7% in the second quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company's stock worth $2,442,000 after acquiring an additional 1,846 shares during the period. Benjamin Edwards Inc. increased its stake in shares of Procter & Gamble by 120.7% in the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company's stock valued at $62,098,000 after purchasing an additional 199,258 shares in the last quarter. Capital Investment Advisory Services LLC boosted its position in Procter & Gamble by 13.8% during the first quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company's stock worth $6,426,000 after purchasing an additional 4,562 shares in the last quarter. World Investment Advisors boosted its position in Procter & Gamble by 6.0% during the first quarter. World Investment Advisors now owns 50,913 shares of the company's stock worth $8,677,000 after purchasing an additional 2,886 shares in the last quarter. Finally, Concurrent Investment Advisors LLC grew its holdings in Procter & Gamble by 26.4% in the first quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company's stock valued at $20,451,000 after purchasing an additional 25,059 shares during the period. Hedge funds and other institutional investors own 65.77% of the company's stock.
Insider Buying and Selling
In other Procter & Gamble news, CEO Jon R. Moeller sold 11,684 shares of the firm's stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $1,778,655.32. Following the completion of the sale, the chief executive officer directly owned 319,932 shares of the company's stock, valued at $48,703,248.36. This trade represents a 3.52% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jennifer L. Davis sold 3,227 shares of the business's stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $491,246.21. Following the transaction, the chief executive officer directly owned 61,764 shares in the company, valued at approximately $9,402,333.72. The trade was a 4.97% decrease in their position. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock worth $23,421,279 over the last quarter. Corporate insiders own 0.20% of the company's stock.
Analyst Ratings Changes
PG has been the topic of a number of recent analyst reports. Bank of America decreased their target price on Procter & Gamble from $180.00 to $174.00 and set a "buy" rating on the stock in a research report on Wednesday, October 8th. JPMorgan Chase & Co. decreased their price objective on shares of Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating on the stock in a report on Friday, October 10th. BNP Paribas Exane cut their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a research note on Tuesday, September 23rd. Berenberg Bank raised their price target on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a research note on Wednesday, September 17th. Finally, UBS Group lowered their price objective on Procter & Gamble from $180.00 to $176.00 and set a "buy" rating on the stock in a report on Wednesday, October 8th. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $172.21.
Check Out Our Latest Research Report on PG
Procter & Gamble Stock Performance
NYSE:PG opened at $151.53 on Friday. The company has a market cap of $354.66 billion, a P/E ratio of 23.28, a P/E/G ratio of 4.02 and a beta of 0.36. Procter & Gamble Company has a twelve month low of $146.96 and a twelve month high of $180.43. The company's 50-day moving average price is $154.92 and its 200-day moving average price is $158.77. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the prior year, the firm earned $1.40 EPS. Procter & Gamble's quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be paid a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. Procter & Gamble's payout ratio is 64.98%.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
